NWS vs REPL · rev $9.03B vs $825.7M cap
NWS (NWS) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
NWS (NWS) common stock.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported NWS revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 6.8% from 2025-06-30 to 2026-06-30. NWS currently screens at market cap $0.
REPL does not have a complete income-statement cache yet.
NWS currently screens at market cap $0. REPL currently screens at market cap $825.7M.
Not investment advice. Open the NWS and REPL stock pages for the full models.
Not investment advice.